NRC
NRC HealthBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Primary-source evidence improved after earnings: record TRCV, resumed year-over-year revenue growth, healthy Q1 cash generation, and management commentary around stronger sales and retention all support a modestly positive thesis [#8-K-2026-04-28-Earnings] [#PR-2026-03-04].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +5.6.
What can break
Low coverage and no visible analyst-target dataset reduce external validation and make post-earnings price discovery noisier.
Momentum
81
Value
54
Sentiment
37
Setup hits (3d)
— · Net —
AI TargetsBase $17.50 · Bull $20.00 · Bear $14.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net —
Why
Momentum81 · Δ7d +5.6
Value54 · Δ7d -0.6
Sentiment37 · Δ7d -2.6
So what
Strength-led posture. Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
81
34% active weight
Current posture
7d trendSoftening
Δ7d
+5.6
Δ21d
+7.4
Value
54
32% active weight
Current posture
7d trendFlat
Δ7d
-0.6
Δ21d
-0.2
Sentiment
37
33% active weight
Current posture
7d trendSoftening
Δ7d
-2.6
Δ21d
+0.0
Why this grade
Composite grade B. Momentum 81.1 / Value 53.7 / Sentiment 37.5
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$456.37M
Beta
0.50
Shares Out
22.66M
P/E (TTM)
26.3
P/S (TTM)
3.06
P/FCF (TTM)
812.90
Rev YoY
-3.4%
EPS YoY
-22.2%
Gross Margin
+62.1%
Op Margin
+19.8%
Net Debt
$58.47M
Current Ratio
0.53
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology